$3.06
+0.18
(+6.25%)▲
3.76%
Downside
Day's Volatility :7.97%
Upside
4.38%
73.2%
Downside
52 Weeks Volatility :86.31%
Upside
48.91%
Period | Maia Biotechnology Inc | Index (Russel 2000) |
---|---|---|
3 Months | 14.18% | 0.0% |
6 Months | -7.55% | 0.0% |
1 Year | 41.67% | 0.0% |
3 Years | -31.39% | -27.4% |
Market Capitalization | 69.0M |
Book Value | $0.13 |
Earnings Per Share (EPS) | -1.62 |
Wall Street Target Price | 12.63 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -107.11% |
Return On Equity TTM | -559.56% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | -1.62 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 312.75%
Sell
Neutral
Buy
Maia Biotechnology Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Maia Biotechnology Inc | 19.07% | -7.55% | 41.67% | -31.39% | -31.39% |
Regeneron Pharmaceuticals, Inc. | -16.73% | -13.48% | -0.36% | 33.18% | 155.61% |
Biontech Se | -8.7% | 18.88% | 11.29% | -54.26% | 538.49% |
Alnylam Pharmaceuticals, Inc. | -0.55% | 75.43% | 58.71% | 41.13% | 193.04% |
Vertex Pharmaceuticals Incorporated | 11.43% | 24.19% | 29.58% | 160.04% | 155.08% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Maia Biotechnology Inc | NA | NA | NA | 0.0 | -5.6 | -1.07 | NA | 0.13 |
Regeneron Pharmaceuticals, Inc. | 20.49 | 20.49 | 1.21 | 44.74 | 0.17 | 0.07 | NA | 272.04 |
Biontech Se | 160.8 | NA | 0.04 | -2.8 | -0.03 | -0.02 | NA | 85.17 |
Alnylam Pharmaceuticals, Inc. | NA | NA | -0.49 | -2.18 | -15.01 | -0.03 | NA | 0.25 |
Vertex Pharmaceuticals Incorporated | 32.84 | NA | 1.21 | 0.16 | -0.03 | 0.13 | NA | 57.26 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Maia Biotechnology Inc | Buy | $69.0M | -31.39% | NA | 0.0% |
Regeneron Pharmaceuticals, Inc. | Buy | $91.1B | 155.61% | 20.49 | 33.61% |
Biontech Se | Buy | $26.5B | 538.49% | 160.8 | -18.75% |
Alnylam Pharmaceuticals, Inc. | Buy | $34.8B | 193.04% | NA | -15.86% |
Vertex Pharmaceuticals Incorporated | Buy | $121.6B | 155.08% | 32.84 | -4.74% |
Insights on Maia Biotechnology Inc
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.7% return, outperforming this stock by 17.0%
maia biotechnology, inc. is a targeted therapy, immune-oncology company, focused on development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. a privately-held company based in chicago, maia is led by a passionate, principled and highly experienced management team with significant drug development experience, committed to advancing promising agents into trials in humans clinical trials. maia’s business strategy is designed to advance a strong value proposition for its portfolio of potentially novel compounds. maia controls risk and enhances its opportunity for success by diversifying and generating this portfolio of assets with a variety of compounds with novel mechanisms of action which have potential activity in multiple tumor types. maia’s business model involves placing drug candidates in their own dedicated, r&d focused subsidiary company, which is supported by the common infrastru
Organization | Maia Biotechnology Inc |
Employees | 13 |
CEO | Dr. Vlad Vitoc M.B.A., M.D. |
Industry | Miscellaneous |
Cactus Acquisition Corp 1 Ltd
$3.06
+6.25%
Rigel Resource Acquisition Corp
$3.06
+6.25%
Everi Holdings Inc
$3.06
+6.25%
Anfield Us Equity Sector Rotation Etf
$3.06
+6.25%
3edge Dynamic Fixed Income Etf
$3.06
+6.25%
Direxion Daily Csi 300 China A Share 2x Shares Etf
$3.06
+6.25%
Dfa Dimensional Us Real Estate Etf
$3.06
+6.25%
Sow Good Inc
$3.06
+6.25%
Uscb Financial Holdings Inc
$3.06
+6.25%